Clinical Trials Directory

Trials / Completed

CompletedNCT01711294

Evaluation of PCLs Using Three EUS-FNA Needles

A Multicenter, Prospective, Randomized Study on Endosonographic Evaluation of Pancreatic Cystic Lesions Using 22 G, 19 G, and Flexible 19 G Fine Needle Aspiration

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
250 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-mucinous cysts.

Conditions

Interventions

TypeNameDescription
DEVICE19 G Flex NeedleFine Needle Aspiration of PCL with a 19 G Flex needle. If unsuccessful, a salvage procedure will be done with 19 G or 22 G needle.
DEVICE22 G NeedleFine Needle Aspiration of PCL with a 22 G needle. If unsuccessful, a salvage procedure will be done with 19 G Flex needle.
DEVICE19 G NeedleFine Needle Aspiration of PCL with a 19 G needle. If unsuccessful, a salvage procedure will be done with 19 G Flex needle.

Timeline

Start date
2013-01-08
Primary completion
2017-06-06
Completion
2019-12-18
First posted
2012-10-22
Last updated
2021-01-15
Results posted
2020-11-12

Locations

8 sites across 3 countries: United States, China, India

Source: ClinicalTrials.gov record NCT01711294. Inclusion in this directory is not an endorsement.